ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 680

$1.01M Total Retail Price of All Prescriptions

Rank: 80 out of 680

657 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,728 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 550 501 1 2
HYDROCODONE-ACETAMINOPHEN 468 369 S3 2 4
CARVEDILOL 427 372 3 23
AMLODIPINE BESYLATE 379 346 4 1
OMEPRAZOLE 348 277 5 7
PRAVASTATIN SODIUM 331 220 6 10
ZOLPIDEM TARTRATE 328 237 7 17
FUROSEMIDE 300 236 8 6
METFORMIN HCL 248 197 9 8
GABAPENTIN 245 227 10 15
ATORVASTATIN CALCIUM 206 173 11 11
SIMVASTATIN 204 187 12 3
PANTOPRAZOLE SODIUM 201 161 13 30
LISINOPRIL 189 158 14 5
TAMSULOSIN HCL 185 157 15 34
TRAMADOL HCL-ACETAMINOPHEN 184 141 16 153
WARFARIN SODIUM 181 135 17 20
TRAMADOL HCL 179 113 18 18
NAMENDA 157 157 19 35
NEXIUM 152 144 20 16
CYMBALTA 151 118 21 46
METOPROLOL TARTRATE 147 117 22 12
DONEPEZIL HCL 141 141 23 27
CLOPIDOGREL 141 137 23 26
POTASSIUM CHLORIDE 138 107 25 14
SERTRALINE HCL 135 114 26 28
HYDROCHLOROTHIAZIDE 127 92 27 9
CITALOPRAM HBR 127 98 27 22
METOPROLOL SUCCINATE 122 86 29 13
FLUTICASONE PROPIONATE 118 94 30 41
ESCITALOPRAM OXALATE 116 100 31 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 111 32 37
CIPROFLOXACIN HCL 113 104 33 57
POLYETHYLENE GLYCOL 3350 112 86 34 62
ADVAIR DISKUS 112 91 34 53
LOSARTAN POTASSIUM 111 104 36 21
TRAZODONE HCL 108 89 37 48
ALENDRONATE SODIUM 105 105 38 32
AMITRIPTYLINE HCL 102 71 R 39 47
FLUOXETINE HCL 96 74 40 74
RAMIPRIL 95 94 41 69
MELOXICAM 92 69 42 24
QUETIAPINE FUMARATE 91 81 43 64
FENOFIBRATE 87 62 44 66
CELEBREX 82 65 45 90
LOSARTAN-HYDROCHLOROTHIAZIDE 78 69 46 51
MIRTAZAPINE 77 69 47 78
PROMETHAZINE HCL 76 43 R 48 96
PLAVIX 75 72 49 39
ALLOPURINOL 74 66 50 33
NITROFURANTOIN 69 58 51 269
PREDNISONE 66 41 52 50
CRESTOR 66 61 52 25
METFORMIN HCL ER 62 62 54 54
TRICOR 61 48 55 98
AMLODIPINE BESYLATE-BENAZEPRIL 59 31 56 43
ROPINIROLE HCL 58 56 57 99
LANTUS 56 42 58 49
HUMALOG 55 29 59 196
AZITHROMYCIN 55 43 59 42
FINASTERIDE 55 55 59 109
DIGOXIN 54 46 62 58
METOCLOPRAMIDE HCL 54 47 62 118
DIOVAN HCT 53 45 64 55
ISOSORBIDE MONONITRATE ER 53 35 64 59
ATENOLOL 53 37 64 19
SYNTHROID 51 36 67 38
LOVASTATIN 50 40 68 44
BENICAR HCT 50 37 68 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.